Revealing the role of regulatory b cells in cancer: development, function and treatment significance
Cancer Immunology, Immunotherapy · 2025
DOI: 10.1007/s00262-025-03973-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Ruyu Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China. Hauptthemen laut MEDLINE: Neoplasms, B-Lymphocytes, Regulatory. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
B cells are essential components of the immune response, primarily recognized for their ability to produce antibodies. However, emerging research reveals their important roles in regulating immune responses and influencing tumor development, independent of antibodies. The connection between tumor progression and alterations in the tumor microenvironment is well-established, as immune infiltrating cells can enhance the survival of tumor cells by modifying their surroundings. Despite this, the majority of studies have focused on T cells and macrophages, creating a gap in our understanding of B cells. Regulatory B cells (Bregs) represent a crucial subpopulation that plays a significant role in maintaining immune balance. They may have a substantial impact on tumor immunity by negatively regulating tumor-infiltrating immune cells. This paper reviews the existing literature on Bregs, examining their development, phenotypes, functions, and the mechanisms through which they exert their regulatory effects. Furthermore, we highlight their potential interventional roles and prognostic significance in cancer therapy. By addressing the current gaps in knowledge regarding Bregs within tumors, we hope to inspire further research that could lead to innovative cancer treatments and improved outcomes for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China.
- Department of Hematology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China. lily312@dmu.edu.cn.
Zitieren
APA
Ye, R., Li, S., Li, Y., Shi, K., & Li, L. (2025). Revealing the role of regulatory b cells in cancer: development, function and treatment significance. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-03973-w
Vancouver
Ye R, Li S, Li Y, Shi K, Li L. Revealing the role of regulatory b cells in cancer: development, function and treatment significance. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-03973-w
BibTeX
@article{Ye2025,
author = {Ye, Ruyu and Li, Sijia and Li, Yuxiao and Shi, Kaixin and Li, Li},
title = {Revealing the role of regulatory b cells in cancer: development, function and treatment significance},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
doi = {10.1007/s00262-025-03973-w}
}
EUVIMED